Clinical Trial

A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC

Name: A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC — clinical trial record (NCT07760519)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This will be a single-arm, multicenter, prospective, observational, real-world study and the data source is the patients' medical record at each site. A total of 78 patients will be enrolled in the study.

Trial Details

NCT Number	NCT07760519
Lead Sponsor	AstraZeneca
Conditions	Carcinoma, Non-Small-Cell Lung
Enrollment	78 participants
Start Date	2026-09-30
Primary Completion	2030-04-30 (estimated)
Study Completion	2030-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-12